Overexpression of <i>DUOX2</i> mediates doxorubicin resistance and predicts prognosis of pancreatic cancer.

Lyu, Peng-Wei; Xu, Xiao-Dong; Zong, Ke; Qiu, Xin-Guang

Overexpression of DUOX2 mediates doxorubicin resistance and predicts prognosis of pancreatic cancer.

Lyu, Peng-Wei; Xu, Xiao-Dong; Zong, Ke; Qiu, Xin-Guang.

Afiliação

Lyu PW; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xu XD; Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zong K; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qiu XG; Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Gland Surg ; 11(1): 115-124, 2022 Jan.

Article em En | MEDLINE | ID: mdl-35242674

Palavras-chave

Pancreatic cancer; chemoresistance; nicotinamide adenine dinucleotide phosphate oxidase family (NOX family); prognosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Gland Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação:

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google